-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-disposition-comments.pdf
March 31, 2025 - Further, those administering the outcome
assessment were not blinded to treatment status,
possibly … may have similar outcomes to one another nor to women
and mothers, given the effects of hormonal treatments … Thus, individuals who have had chest
masculinization surgery or hormonal treatments should
be disaggregated
-
effectivehealthcare.ahrq.gov/health-topics/uterine-diseases
-
effectivehealthcare.ahrq.gov/health-topics/herniated-disk
-
effectivehealthcare.ahrq.gov/health-topics/tendinitis
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-prepub-final-research-appendix-e.xlsx
January 01, 2024 - All Baseline (Pre-treatment) . AXOS+ bread 44 3.73 0.1281423214 0.85 . . . … All 3 (During treatment) wk AXOS+ bread 44 3.69 0.1477405588 0.98 . . . … All Baseline (Pre-treatment) . Placebo bread 44 3.51 0.1190969811 0.79 . . . … All 3 (During treatment) wk Placebo bread 44 3.45 0.1160818677 0.77 . . . … Walton 2012 22657950 Fecal/defecation frequency BM/week All Baseline (Pre-treatment) .
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-final-appendix-e.xlsx
January 01, 2024 - All Baseline (Pre-treatment) . AXOS+ bread 44 3.73 0.1281423214 0.85 . . . … All 3 (During treatment) wk AXOS+ bread 44 3.69 0.1477405588 0.98 . . . … All Baseline (Pre-treatment) . Placebo bread 44 3.51 0.1190969811 0.79 . . . … All 3 (During treatment) wk Placebo bread 44 3.45 0.1160818677 0.77 . . . … Walton 2012 22657950 Fecal/defecation frequency BM/week All Baseline (Pre-treatment) .
-
effectivehealthcare.ahrq.gov/health-topics/vaginal-bleeding
-
effectivehealthcare.ahrq.gov/health-topics/soft-tissue-sarcoma
-
effectivehealthcare.ahrq.gov/products/acute-pain-ems/research
-
effectivehealthcare.ahrq.gov/health-topics/heart-transplantation
-
effectivehealthcare.ahrq.gov/health-topics/sports-injuries
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholder-engagement-benefits_white-paper.pdf
March 01, 2014 - systematic reviews that gather, evaluate, and synthesize the vast array of evidence
on medical tests, treatments … better targeting and responding to
consumer needs and to better
understanding of the conditions or
treatments … That they feel somehow that the approval or disapproval of the treatment is going to be
down to them … get patients coming to speak who are complete outliers to the general experience of patients on that
treatment … life expectancy but the patient speaking to you is the
person who has actually lived 5years on the treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/long-term-care-adults_executive.pdf
November 01, 2012 - object is to help
consumers, health care providers,
and others in making informed
choices among treatment … Effectiveness
Reviews, the program supports
systematic appraisals of existing
scientific evidence regarding
treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_disposition-comments.pdf
May 29, 2013 - nonfatal sequelae of DVT such as phlegmasia, post-thrombotic syndrome, bleeding
complications from therapeutic … weight heparin
We have added additonal text regarding
the mechanism of action of these agents
under “Therapies … Similarly,
because the rates of events are so low in
patients with pharmacological treatment,
exposing … with CKD might expensive and difficult given the
lack of data on both risks and benefits of different therapeutic … involved that other guidelines such
as the ACCP had clearly established the
role of pharmacologic therapies
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cerebral-palsy-feeding_research-protocol.pdf
June 12, 2012 - intake), and concurrent medications that potentially have gastrointestinal
side effects may influence treatment … www.effectivehealthcare.ahrq.gov/
Source: www.effectivehealthcare.ahrq.gov
Published Online: June 12, 2012
treatment … Practice parameter: pharmacologic treatment of spasticity in
children and adolescents with cerebral … "[mesh] OR
"occupational therapy"[tiab] OR "Behavior Therapy"[mesh] OR "behavior therapy"[mesh]
OR … " OR KW="Behavioral Therapy" OR
KW="Behavior Therapy" OR KW="Behavior Modification" OR KW="Behavior"
-
effectivehealthcare.ahrq.gov/products/partial-breast-irradiation/research
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/urinary-incontinence
-
effectivehealthcare.ahrq.gov/products/asthma-nitric-oxide/research
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/clostridium-difficile
-
effectivehealthcare.ahrq.gov/sites/default/files/tnd-0855-170515.pdf
April 28, 2017 - effective on
glycemic control for patients with diabetes (type 1 and type 2) compared with
conventional treatments … Diabetes technology & therapeutics. Nov
2012;14(11):1060-1067.
29. Katalenich BS, L. Liu, S. … Clinical therapeutics.
Jun 1 2015;37(6):1216-1225.
30. Carral FAM, C. Fernandez, J. J. … Diabetes technology & therapeutics. Aug 2015;17(8):563-570. … Search Strategy for RCT’s “((((((((groups[tiab])) OR (trial[tiab]))
OR (randomly[tiab])) OR (drug therapy